Multiple drug-resistant tuberculosis

Infectious Disease Clinics of North America

Volumn 12, Issue 1, 1998, Pages 157-172

  Bradford, W Z ^a   Daley, C L ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; CAPREOMYCIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; IMIPENEM; ISONIAZID; KANAMYCIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; RIFAMYCIN; STREPTOMYCIN; THIOACETAZONE; TUBERCULOSTATIC AGENT;

DRUG MONITORING; HISTORY OF MEDICINE; HUMAN; LUNG TUBERCULOSIS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; REVIEW; TUBERCULOSIS CONTROL;

EID: 0031916353     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70415-3     Document Type: Article

References (52)

1. American Thoracic Society Treatment of tuberculosis and tuberculosis infection in adults and children Am Rev Respir Dis 134 1986 355 363
2. American Thoracic Society Treatment of tuberculosis and tuberculosis infection in adults and children Am Rev Respir Dis 149 1994 1359 1374
3. I. Ben-Dov G.R. Mason Drug-resistant tuberculosis in a southern California hospital: Trends from 1969 to 1984 Am Rev Respir Dis 135 1987 1307 1310
4. P.J. Bifani B.B. Plikaytis V. Kapur Origin and interstate spread of New York City multidrug-resistant Mycobacterium tuberculosis clone family JAMA 275 1996 452 457
5. A.B. Bloch G.M. Cauthen I.M. Onorato Nationwide survey of drug-resistant tuberculosis in the United States JAMA 271 1994 665 671
6. T. Bodmer G. Zurcher P. Imboden Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis J Antimicrob Chemother 35 1995 345 348
7. W.Z. Bradford J.N. Martin A.L. Reingold The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA Lancet 348 1996 928 931
8. British Medical Research Council Treatment of pulmonary tuberculosis with streptomycin and para-aminosalicylic acid: A Medical Research Council investigation BMJ 2 1950 1073 1085
9. I.D. Brobowitz Ethambutol-isoniazid vs. streptomycin-ethambutol-isoniazid in original treatment of cavitary tuberculosis Am Rev Respir Dis 109 1974 548 553
10. W.J. Burman C.B. Dalton D.L. Cohn A cost-effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis Chest 112 1997 63 70
11. G. Canetti Host factors and chemotherapy of tuberculosis V.C. Barry Chemotherapy of Tuberculosis 1964 Butterworth London 180 181
12. Centers for Disease Control and Prevention Recommendations for the management of persons exposed to multidrug resistant tuberculosis MMWR 41 No. RR-11 1992 59 71
13. Centers for Disease Control and Prevention Initial therapy for tuberculosis in the era of multidrug resistance: Recommendations of the Advisory Council for the Elimination of Tuberculosis MMWR 42 RR-7 1993 1 8
14. D.L. Cohn F. Bustreo M.C. Raviglione Drug-resistant tuberculosis: Review of the worldwide situation and the WHO/IUATLD Global Surveillance Project: International Union Against Tuberculosis and Lung Disease Clin Infect Dis 24 suppl 1 1997 S121 S130
15. M.N. Cynamon G.S. Palmer In vitro activity of amoxacillin in combination with clavulanic acid against Mycobacterium tuberculosis Antimicrob Agents Chemother 24 1983 429 431
16. C.L. Daley P.M. Small G.F. Schecter An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: An analysis using restriction-fragment-length polymorphisms N Engl J Med 326 1992 231 235
17. H.L. David Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis Appl Microbiol 20 1970 810 814
18. B. Doster G.J. Caras D.E. Snider A continuing survey of primary drug resistance in tuberculosis, 1961 to 1968: A U.S. Public Health Service cooperative study Am Rev Respir Dis 113 1976 419 425
19. T.R. Frieden P.I. Fujiwara R.M. Washko Tuberculosis in New York City: Turning the tide N Engl J Med 333 1995 229 233
20. T.R. Frieden L.F. Sherman K.L. Maw A multi-institutional outbreak of highly drug-resistant tuberculosis: Epidemiology and clinical outcomes JAMA 276 1996 1229 1235
21. T.R. Frieden T. Sterling A. Pablos-Mendez The emergence of drug-resistant tuberculosis in New York City N Engl J Med 328 1993 521 526
22. P.I. Fujiwara S.V. Cook C.M. Rutherford A continuing survey of drug-resistant tuberculosis, New York City, April 1994 Arch Intern Med 157 1997 531 536
23. M. Goble M.D. Iseman L.A. Madsen Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin N Engl J Med 328 1993 527 532
24. M. Goyal R.J. Shaw D.U. Banerjee Rapid detection of multidrug-resistant tuberculosis Eur Respir J 10 1997 1120 1124
25. Hong Kong Chest Service/British Medical Research Council A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampin Tuber Lung Dis 73 1992 59 67
26. M.D. Iseman L. Madsen M. Goble Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis Am Rev Respir Dis 141 1990 623 625
27. M.D. Iseman Treatment of multidrug resistant tuberculosis N Engl J Med 329 1993 784 791
28. N. Kennedy L. Berger J. Curran Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis Clin Infect Dis 22 1996 827 833
29. J.H. Kent The epidemiology of multidrug-resistant tuberculosis in the United States Med Clin North Am 77 1993 1391 1409
30. S. Kohno H. Koga M. Kaku Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis Chest 102 1992 1815 1818
31. D.E. Kopanoff J.O. Kilburn J.L. Glassroth A continuing survey of tuberculosis primary drug resistance in the United States: March 1975 to November 1977: A United States Public Health Service cooperative study Am Rev Respir Dis 118 1978 835 842
32. H.F. Lecoeur C. Truffot-Pernot J.H. Grosset Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide Am Rev Respir Dis 140 1989 1189 1193
33. A. Mahmoudi M.D. Iseman Pitfalls in the care of patients with tuberculosis: Common errors and their association with the acquisition of drug resistance JAMA 270 1993 65 68
34. D.A. Mitchison Development of streptomycin resistant strains of tubercle bacilli in pulmonary tuberculosis: Results of simultaneous sensitivity tests in liquid and on solid media Thorax 5 1950 144 161
35. D.A. Mitchison Drug resistance in mycobacteria Br Med Bull 40 1984 84 90
36. D.A. Mitchison A.J. Nunn Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis Am Rev Respir Dis 133 1986 423 430
37. J.M. Musser Antimicrobial agent resistance in mycobacteria: Molecular genetic insights Clin Microbiol Rev 8 1995 496 514
38. J.P. Nadler J. Berger J.A. Nord Amoxicillin-clavulanic acid for treating drug-resistant Mycobacterium tuberculosis Chest 99 1991 1025 1026
39. C.M. Nolan D.L. Williams M.D. Cave Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis Am J Respir Crit Care Med 152 1995 1067 1071
40. M.M. Park A.L. Davis N.W. Schluger Outcome of MDR-TB patients, 1983–1993: Prolonged survival with appropriate therapy Am J Respir Crit Care Med 153 1996 317 324
41. C.A. Peloquin A.A. MacPhee S.E. Berning Malabsorption of antimycobacterial medications [letter] N Engl J Med 329 1993 1122 1123
42. A. Polesky H.W. Farber D.J. Gottlieb Rifampin preventive therapy for tuberculosis in Boston's homeless Am J Respir Crit Care Med 154 1996 1473 1477
43. S. Pretet A. Lebeaut R. Parrot Combined chemotherapy including rifabutin for rifampicin and isoniazid resistant pulmonary tuberculosis Eur Respir J 5 1992 680 684
44. M.C. Raviglione D.E. Snider Jr A. Kochi Global epidemiology of tuberculosis: Morbidity and mortality of a worldwide epidemic JAMA 273 1995 220 226
45. J. Sahai L. Swick S. Tailor Reduced oral absorption of tuberculosis drugs in HIV infection [abstract PI 51] Clin Pharmacol Ther 59 1996 142
46. Singapore Tuberculosis Service/British Medical Research Council Assessment of a daily combined preparation isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis Am Rev Respir Dis 143 1991 707 712
47. D.E. Snider Jr G.M. Cauthen L.S. Farer Drug-resistant tuberculosis [letter] Am Rev Respir Dis 144 1991 732
48. S.M. Stewart J.W. Crofton The clinical significance of low degrees of drug resistance in pulmonary tuberculosis Am Rev Respir Dis 1964 811 829
49. B.O. Swai J.A. Aluoch W.A. Githui Controlled clinical trial of a regimen of two durations for the treatment of isoniazid resistant pulmonary tuberculosis Tubercle 69 1988 5 14
50. S.E. Weis P.C. Slocum F.X. Blais The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis N Engl J Med 330 1994 1179 1184
51. C.L. Woodley J.O. Kilburn In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin Am Rev Respir Dis 126 1982 586 587
52. M. Zierski Prospects of retreatment of chronic resistant pulmonary tuberculosis: A critical review Lung 154 1977 91